Anika Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ANIK on Nasdaq
Location
32 Wiggins Avenue, Bedford, Massachusetts

There are no Buy or Sell transactions made by insiders since 9/11/2023

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cheryl R. Blanchard President, CEO, Director, Director $6.16M Mar 15, 2024
Michael L. Levitz EVP, CFO, Treasurer $1.76M Mar 15, 2024
David Colleran EVP, General Counsel, Corp Sec $1.35M Mar 15, 2024
Stephen D. Griffin EVP, CFO and Treasurer $993K Jun 3, 2024
Glenn R. Larsen Director $931K Jul 9, 2024
Susan Vogt Director $930K Jul 9, 2024
John B. Henneman III Director $921K Jul 9, 2024
Stephen Richard Director $869K Jul 9, 2024
Sheryl L. Conley Director $733K Jul 9, 2024
Gary P. Fischetti Director $708K Jul 9, 2024
Thomas Finnerty EVP, Human Resources $590K Mar 9, 2022
Jeffery S. Thompson Director $588K Jun 14, 2023
Anne Nunes SVP, Chief Operations Officer $567K Mar 15, 2024
William R. Jellison Director $231K Jul 9, 2024
Raymond J. Land Director $226K Jun 16, 2021
James Loerop EVP Business Development $182K Jul 8, 2021
Joseph H. Capper Director $161K Jul 9, 2024

Recent Insider Transactions by Companies or Individuals for Anika Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.